Ozone therapy in cancer treatment: State of the art

Ozone: Science and Engineering

Volumn 30, Issue 6, 2008, Pages 398-404

  Menéndez, Silvia ^a   Cepero, Janet ^b   Borrego, Luis ^c  

^a Ozone Research Center Havana   (Cuba)

^b National Oncology and Radiobiology Institute   (Cuba)

^c Hospital General Universitario V I Lenin   (Cuba)

Author keywords

Chemotherapy; Erhlich ascitic tumor; Lewis' lung carcinoma; Metastasis; Ozone; Prostatic adenocarcinoma; Radiotherapy; Sarcoma 37

Indexed keywords

ANIMAL CELL CULTURE; ANIMALS; BIOLOGICAL ORGANS; CHEMOTHERAPY; COBALT; EVAPORATIVE COOLING SYSTEMS; OZONE; PATHOLOGY; RADIATION EFFECTS; TRANSITION METALS; TUMORS;

ERHLICH ASCITIC TUMOR; LEWIS' LUNG CARCINOMA; METASTASIS; PROSTATIC ADENOCARCINOMA; SARCOMA 37;

GASES;

ANIMALIA; MUS;

EID: 57349109346     PISSN: 01919512     EISSN: 15476545     Source Type: Journal    
DOI: 10.1080/01919510802473724     Document Type: Article

References (44)

1. Ajamieh, H.H., S. Menéndez, G. Martínez, E. Candelario-Jalil, L. Re, A. Giuliani, and O.S. León, "Effects of Ozone Oxidative Preconditioning on Nitric Oxide Generation and Cellular Redox Balance in a Rat Model of Hepatic Ischaemia-Reperfusion", Liver Int., 24: 55-62 (2004).
2. Ajamieh, H.H., J. Berlanga, N. Merino, G. Martínez-Sánchez, E. Candelario-Jalil, S. Menéndez, A. Giuliani, and O.S. León, "Role of Protein Synthesis in the Protection Conferred by Ozone Oxidative Preconditioning in Hepatic Ischemia/Reperfusion", Transpl. Int., 18: 604-612 (2005).
3. Argiles, J.M., R. Moore-Carrasco, G. Fuster, S. Busquets, and F.J. López-Soriano, "Cancer Cachexia: The Molecular Mechanisms", Int. J. Biochem. Cell B, 35:405-409 (2003).
4. Bailar, J.C. and H.L. Gornih, "Cancer Undefeated", N. Engl. J. Med., 336:1569-1574 (1997).
5. Bauer, M.K.A., M. Vogt, and M. Los, "Role of Reactive Oxygen Intermediates in Activation-Induced CD95 (APO-1/Fas) Ligand Expression", J. Biol. Chem., 273:8048-8055 (1998).
6. Bocci, V., Oxygen-Ozone Therapy. A Critical Evaluation. (Dordrecht, The Netherlands: Kluwer Academic Publisher, 2002), pp. 121-314.
7. Borrego, A., Z. Zamora, R. González, Ch. Romay, S. Menéndez, F. Hernández, T. Montero, and E. Rojas, "Protection by Ozone Preconditioning is Mediated by Antioxidant System in Cisplatin Induced Nephrotoxicity in Rats", Mediat Inflamm., 13(1):13-19 (2004).
8. Borrego, A, Z. Zamora, R. González, Ch. Romay, S. Menéndez, F. Hernández, J. Berlanga, and T. Montero, "Ozone/Oxygen Mixture Modifies the Subcellular Redistribution of Bax Protein in Renal Tissue from Rats Treated with Cisplatin", Arch. Med. Res., 37:717-722 (2006).
9. Brahimi-Bruno, C., E. Berra, and J. Pouyssegur, "Hypoxia: The Tumour's Gateway to Progression Along the Angiogenic Pathway", Trends Cell Biol., 11:S32-S36 (2001).
10. 2 are Potent Inducers of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes", J. Biol. Chem., 271: 21793-21797 (1996).
11. Burstein, H.J., S. Gelber, E. Guadagnoli, and J.C. Weeks. "Use of Alternative Medicine by Women with Early-Stage Breast Cancer", N. Engl. J. Med., 340:1733-1739 (1999).
12. Calunga, J.L., M. Bello, M. Chaple, E. Barber, S. Menéndez, and N. Merino, "Ozonoterapia en la glomerulonefritis tóxica experimental por adriamicina", Rev. Invest. Biomed. (Cuba), 23(3):139-143 (2004).
13. Cassileth, B.R. and C.C. Chapman, "Alternative and Complementary Cancer Therapies", Cancer, 77: 1026-1034 (1996).
14. Clavo, B., J.L. Pérez, L. López, G. Suárez, M. Lloret, V. Rodríguez, D. Macías, M. Santana, M.A. Hernández, R. Martín-Oliva, and F. Robaina, "Ozone Therapy for Tumor Oxygenation: A Pilot Study", eCAM, 1(1):93-98 (2004).
15. Dechao, L., U. Eisaku, K. Tsuyoshi, Y. Tetsuya, and O. Tokio, "Reactive Oxygen Species (ROS) Control the Expression of Bcl-2 Family Proteins by Regulating Their Phosphorylation and Ubiquitination", Cancer Sci., 95:644-650 (2004).
16. Eaton, L. "World Cancer Rates Set to Double by 2020", Br. Med. J., 326:728-734 (2003).
17. Giovanni G.G., S. Luca, and M. Michele, "New Dimensions in Cancer Biology and Therapy", J. Cell. Physiol., 183:284-287 (2000).
18. Giunta, R., A. Coppola, C. Luongo, A. Sammartino, S. Guastafierro, A. Grassia, L. Giunta, L. Mascolo, A. Tirelli, and L. Coppola, "Ozonized Autohemotransfusion Improves Hemorheological Parameters and Oxygen Delivery to Tissues in Patients with Peripheral Occlusive Arterial Disease", Ann. Hematol., 80:745-748 (2001).
19. González, R., A. Borrego, Z. Zamora, Ch. Romay, F. Hernández, S. Menéndez, T. Montero, and E. Rojas, "Reversion by Ozone Treatment of Acute Nephrotoxicity Induced by Cisplatin in Rats", Mediat. Inflamm., 13(5/6):307-312 (2004).
20. Harris, A.L., "Hypoxia - A Key Regulatory Factor in tumour growth", Nat. Rev. Cancer, 2:38-47 (2002).
21. Hernández, F., S. Menéndez, and R. Wong, "Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy" Free Radical Biol. Med., 19(1): 115-119 (1995).
22. Hernández, L.A., Oncología. Preguntas y respuestas (Philadelphia, USA:Ed Prous Science, 2001), p. 630.
23. Knight, J.A., "Diseases Related to Oxygen-Derived Free Radicals", Ann. Clin. Lab. Sci., 25(2):111-121 (1995).
24. Larini, A. and V. Bocci, "Effects of Ozone on Isolated Peripheral Blood Mononuclear Cells", Toxicol. in Vitro, 1955-61 (2005).
25. Lebwohl, D. and R. Canetta, "Clinical Development of Platinum Complexes in Cancer Therapy: An Historical Perspective and an Update", Eur. J. Cancer, 34:1522-1534 (1998).
26. León, O.S., S. Menéndez, N. Merino, R. Castillo, S. Sam, L. Pérez, E. Cruz, and V. Bocci, "Ozone Oxidative Preconditioning: A Protection Against Cellular Damage by Free Radicals", Mediat. Inflamm., 7:289-294 (1998).
27. Levi, F., F. Lucchini, E. Negri, P. Boyle, and C. La Vecchia, "Cancer Mortality in Europe, 1990-1994, and an Overview of Trends from 1955 to 1994", Eur. J. Cancer, 35:1477-1516 (1999).
28. Maulik, N. and D.K. Das, "Redox Signaling in Vascular Angiogenesis", Free Radical Biol. Med., 33:1047-1060 (2002).
29. Maxwell, P.H., C.W. Pugh, and P.J. Ratcliffe, "Activation of the HIF Pathway in Cancer", Curr. Opin. Genet. Dev., 11(3):293-299 (2001).
30. Ortiz, A., C. Lorz, M.P. Catalán, T.M. Danoff, Y. Yamasaki, and J. Egido, "Expression of Apoptosis Regulatory Proteins in Tubular Epithelium Stressed in Culture or Following Acute Renal Failure", Kidney Int., 57:969-981 (2000).
31. Pantel, K., R.J. Cote, and O. Fodstad, "Detection and Clinical Importance of Micrometastatic Diseasë ", J. Natl. Cancer Inst., 91:1113-1124 (1999).
32. Romero, A., S. Menéndez, M. Gómez, and J. Ley, "La ozonoterapia en los estadios avanzados de la aterosclerosis obliterante", Angiología, 45(4):146-148 (1993).
33. Salah-Eldin, A., S. Inoue, M. Tsuda, and A. Matsuura, "Abnormal Intracellular Localization of Bax with a Normal Membrane Anchor Domain in Human Lung Cancer Cell Lines", Jpn. J. Cancer Res., 91:1269-1277 (2000).
34. Subarsky, P. and R.P. Hill, "The Hypoxic Tumour Micrenvironment and Metastasis Progression", Clin. Exp. Metastasis, 20:237-250 (2003).
35. Sweet, F., M.S. Kao, S.C.D. Lee, W.L. Hagar, and W.E. Sweet, "Ozone Selectively Inhibits Growth of Human Cancer Cells", Science, 209:931-933 (1980).
36. Szatrowski, T.P. and C.F. Nathan, "Production of Large Amount of Hydrogen Peroxide by Human Tumor Cells", Cancer Res., 5:794-798 (1991).
37. Tisdale, M.J., "Cachexia in Cancer Patients", Nat. Rev. Cancer, 2:862-871 (2002).
38. Toyokuni, S., K. Okamoto, J. Yodoi, and H. Hiai, "Persistent Oxidative Stress in Cancer", FEBS Lett., 358:1-3 (1995).
39. Tylicki, L., G.T. Niew, B. Biedunkiewicz, S. Burakowski, and B. Rutkowski, "Beneficial Clinical Effects of Ozonated Autohemotherapy in Chronically Dialysed Patients with Atherosclerotic Ischemia of the Lower Limbs-Pilot Study", Int. J. Artif. Organs, 24:79-82 (2001).
40. Washüttl, J., R. Viebahn, and I. Steiner, "The Influence of Ozone on Tumor Tissue in Comparison with Healthy Tissue (in vitro)", Ozone-Sci. Eng., 12:65-72 (1990).
41. Winklhofer-Roob, B.M., "Oxygen Free Radicals and Antioxidant in Cystic Fibrosis: The Concept of an Oxidant-Antioxidant Imbalance", Acta Paediat., 395:49-57 (1994).
42. Wu, Y.J., L.L. Muldoon, and E.A. Neuwelt, "The Chemoprotective Agent N-Acetylcysteine Blocks Cisplatin-Induced Apoptosis Through Caspase Signalling Pathway", J. Pharmacol. Exp. Ther., 312:434-431 (2005).
43. Zänker, K.S. and R. Kroczek, "In Vitro Synergistic Activity of 5-Fluorouracil with Low-Dose Ozone Against a Chemoresistant Tumor Cell Line and Fresh Human Tumor Cells", Chemotherapy, 36:147-154 (1990).
44. Zänker, K.S. and R. Kroczek, "The Mystery of a Molecule-Ozone: Antiproliferative, Inmunomodulative, Synergistic to Chemotherapy and Carcinogenic", Proc. of the Ninth Ozone World Congress, New York, USA, Ozone in Medicine, pp. 55-68 (1989).